» Articles » PMID: 36346816

Estimating the Infection Burden of COVID-19 in Malaysia

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Malaysia has reported 2.75 million cases and 31,485 deaths as of 30 December 2021. Underestimation remains an issue due to the underdiagnosis of mild and asymptomatic cases. We aimed to estimate the burden of COVID-19 cases in Malaysia based on an adjusted case fatality rate (aCFR). Data on reported cases and mortalities were collated from the Ministry of Health official GitHub between 1 March 2020 and 30 December 2021. We estimated the total and age-stratified monthly incidence rates, mortality rates, and aCFR. Estimated new infections were inferred from the age-stratified aCFR. The total estimated infections between 1 March 2020 and 30 December 2021 was 9,955,000-cases (95% CI: 6,626,000-18,985,000). The proportion of COVID-19 infections in ages 0-11, 12-17, 18-50, 51-65, and above 65 years were 19.9% (n = 1,982,000), 2.4% (n = 236,000), 66.1% (n = 6,577,000), 9.1% (n = 901,000), 2.6% (n = 256,000), respectively. Approximately 32.8% of the total population in Malaysia was estimated to have been infected with COVID-19 by the end of December 2021. These estimations highlight a more accurate infection burden in Malaysia. It provides the first national-level prevalence estimates in Malaysia that adjusted for underdiagnosis. Naturally acquired community immunity has increased, but approximately 68.1% of the population remains susceptible. Population estimates of the infection burden are critical to determine the need for booster doses and calibration of public health measures.

Citing Articles

Underreporting of Cases in the COVID-19 Outbreak of Borriana (Spain) during Mass Gathering Events in March 2020: A Cross-Sectional Study.

Domenech-Montoliu S, Pac-Sa M, Sala-Trull D, Del Rio-Gonzalez A, Sanchez-Urbano M, Satorres-Martinez P Epidemiologia (Basel). 2024; 5(3):499-510.

PMID: 39189253 PMC: 11348374. DOI: 10.3390/epidemiologia5030034.


Post COVID-19 condition among adults in Malaysia following the Omicron wave: A prospective cohort study.

Tok P, Kang K, Ng S, Ab Rahman N, Syahmi M, Pathmanathan M PLoS One. 2024; 19(1):e0296488.

PMID: 38181017 PMC: 10769055. DOI: 10.1371/journal.pone.0296488.


Outcomes of Pregnancy in COVID-19-Positive Mothers in a Tertiary Centre.

Subramaniam V, Ng B, Phon S, Muhammad Rafiuddin H, Wira Sorfan A, Siti Hajar A Life (Basel). 2023; 13(7).

PMID: 37511865 PMC: 10381457. DOI: 10.3390/life13071491.


Experiences, coping strategies and perspectives of people in Malaysia during the COVID-19 pandemic.

Cheah P, Jalloh M, Cheah P, Ongkili D, Schneiders M, Osterrieder A BMC Public Health. 2023; 23(1):1085.

PMID: 37280573 PMC: 10242592. DOI: 10.1186/s12889-023-15892-5.

References
1.
Sahlu I, Whittaker A . Obtaining Prevalence Estimates of Coronavirus Disease 2019: A Model to Inform Decision-Making. Am J Epidemiol. 2021; 190(8):1681-1688. PMC: 8083389. DOI: 10.1093/aje/kwab079. View

2.
Sam I, Chong Y, Tan C, Chan Y . Low postpandemic wave SARS-CoV-2 seroprevalence in Kuala Lumpur and Selangor, Malaysia. J Med Virol. 2020; 93(2):647-648. PMC: 7436669. DOI: 10.1002/jmv.26426. View

3.
Verity R, Okell L, Dorigatti I, Winskill P, Whittaker C, Imai N . Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020; 20(6):669-677. PMC: 7158570. DOI: 10.1016/S1473-3099(20)30243-7. View

4.
Kawashima T, Nomura S, Tanoue Y, Yoneoka D, Eguchi A, Ng C . Excess All-Cause Deaths during Coronavirus Disease Pandemic, Japan, January-May 2020. Emerg Infect Dis. 2021; 27(3):789-795. PMC: 7920666. DOI: 10.3201/eid2703.203925. View

5.
Liu Y, Morgenstern C, Kelly J, Lowe R, Jit M . The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories. BMC Med. 2021; 19(1):40. PMC: 7861967. DOI: 10.1186/s12916-020-01872-8. View